CellaVision AB CEVI
OMXSTO · İsveç · Sağlık Teknolojisi
SEK 172,40-0,80 (-%0,46)
Piyasa kapalı· · SEK · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa kapalı· · SEK · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
In recent weeks, global markets have experienced a mix of volatility and optimism, with small-cap equities leading the advance as evidenced by the Russell 2000 Index's significant rise. This positive momentum comes amid geopolitical developments and fluctuating energy prices, which have impacted broader market sentiment and economic indicators relevant to small-cap companies. In this environment, identifying stocks that are potentially undervalued can offer intriguing opportunities for...
As European markets navigate a period of uncertainty, highlighted by the pan-European STOXX Europe 600 Index's recent decline and mixed economic signals such as the eurozone's GDP contraction, investors are increasingly looking for opportunities in small-cap stocks. In this environment, companies that demonstrate strong fundamentals and have insider buying activity may present intriguing prospects for those seeking potential value plays amidst broader market fluctuations.
As European markets grapple with economic uncertainties and geopolitical developments, the pan-European STOXX Europe 600 Index recently experienced a modest decline of 0.53% in local currency terms. Amid this backdrop, small-cap stocks are drawing attention for their potential to offer unique opportunities, particularly when insider activity suggests confidence in a company's prospects. In exploring undervalued small caps with notable insider action, investors often look for companies that...
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.